CRSP   $48.02  -1.01% Market Closed After Close 48.4936 0.99%

CRISPR Therapeutics AG
Total Cash 2.00B
totalCashPerShare 23.502
EBITDA -335.17M
Total Debt 231.30M
quickRatio 15.659
currentRatio 15.728
Total Revenue 202.23M
debtToEquity 11.676
Revenue/Share 2.483
ROA -0.097720005
ROE -0.14001
grossProfits
freeCashflow -51.44M
operatingCashflow -121.76M
earningsGrowth
revenueGrowth -0.993
grossMargins -1.39681
ebitdaMargins -1.65741
operatingMargins -292.57254
profitMargins -1.31438
enterpriseValue 2.40B
forwardPE -9.739459
floatShares 83.77M
sharesOutstanding 85.17M
sharesShort 17.56M
sharesShortPriorMonth 17.44M
dateShortInterest
sharesPercentSharesOut 0.21%
heldPercentInsiders 0.02%
heldPercentInstitutions 0.80%
Short Ratio help_outline 16.87%
shortPercentOfFloat 0.23%
impliedSharesOutstanding
bookValue 23.293
Price To Book help_outline 2.09
earningsQuarterlyGrowth
netIncomeToCommon -265.80M
trailingEps -3.20%
forwardEps -4.99%
enterpriseToEbitda -7.15
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.42 3Q 2024
institutionsCount 591
lastUpdated Oct. 21, 2024, 9:32 p.m.